XML 18 R7.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Operating activities    
Net income $ 37,290 $ 33,125
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 449 488
Net amortization of investments 4,483 5,979
Deferred income taxes (526) 831
Net realized losses on investments 23 1,142
Net unrealized (gains) losses on equity securities (2,800) 314
Share-based compensation 509 782
Changes in operating assets and liabilities:    
Premiums receivable, net (12,542) (15,658)
Accrued interest receivable 111 177
Deferred policy acquisition costs (816) (1,350)
Amounts held by others 1 (7,855)
Other assets (947) 942
Reserves for loss and loss adjustment expenses (3,363) 11,756
Unearned premiums 7,593 10,040
Reinsurance balances 8,317 (8,828)
Amounts held for others and policyholder deposits 1,976 1,787
Accounts payable and other liabilities (189) 3,312
Net cash provided by operating activities 39,569 36,984
Investing activities    
Purchases of investments held-to-maturity (67,571) (38,129)
Purchases of investments available-for-sale (27,356) (52,211)
Purchases of equity securities (2,620) (4,339)
Purchases of short-term investments (79,224) (100,059)
Proceeds from maturities of investments held-to-maturity 73,865 52,584
Proceeds from sales and maturities of investments available-for-sale 60,494 66,480
Proceeds from sales of equity securities   282
Proceeds from sales and maturities of short-term investments 23,679 13,465
Proceeds from redemptions of other investments   130
Purchases of property and equipment (148) (1,004)
Net cash used in investing activities (18,881) (62,801)
Financing activities    
Proceeds from stock option exercises 20 67
Finance lease purchases (23)  
Dividends to shareholders (9,783) (8,633)
Net cash used in financing activities (9,786) (8,566)
Change in cash and cash equivalents 10,902 (34,383)
Cash and cash equivalents at beginning of period 40,344 55,559
Cash and cash equivalents at end of period $ 51,246 $ 21,176